Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancerKLIJN, Jan G. M; SETYONO-HAN, Buddy; FOEKENS, John A et al.Steroids. 2000, Vol 65, Num 10-11, pp 825-830, issn 0039-128XConference Paper

Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predispositionOBDEIJN, Inge-Marie A; LOO, Claudette E; RIJNSBURGER, Adriana J et al.Breast cancer research and treatment. 2010, Vol 119, Num 2, pp 399-407, issn 0167-6806, 9 p.Article

Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell linesHOLLESTELLE, Antoinette; NAGEL, Jord H. A; RIAZ, Muhammad et al.Breast cancer research and treatment. 2010, Vol 121, Num 1, pp 53-64, issn 0167-6806, 12 p.Article

Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancerWASIELEWSKI, Marijke; OUT, Astrid A; DEVILEE, Peter et al.Breast cancer research and treatment. 2010, Vol 124, Num 3, pp 635-641, issn 0167-6806, 7 p.Article

Sensitivity to First-Line Chemotherapy for Metastatic Breast Cancer in BRCA1 and BRCA2 Mutation CarriersKRIEGE, Mieke; SEYNAEVE, Caroline; VAN DEN OUWELAND, Ans et al.Journal of clinical oncology. 2009, Vol 27, Num 23, pp 3764-3771, issn 0732-183X, 8 p.Article

Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profilingJANSEN, Maurice P. H. M; FOEKENS, John A; KLIJN, Jan G. M et al.Journal of clinical oncology. 2005, Vol 23, Num 4, pp 732-740, issn 0732-183X, 9 p.Article

Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testingLODDER, Litanja; FRETS, Petra G; TRIJSBURG, R. Willem et al.American journal of medical genetics. 2003, Vol 119A, Num 3, pp 266-272, issn 0148-7299, 7 p.Article

The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case familiesOLDENBURG, Rogier A; KROEZE-JANSEMA, Karin; MEIJERS-HEIJBOER, Hanne et al.Cancer research (Baltimore). 2003, Vol 63, Num 23, pp 8153-8157, issn 0008-5472, 5 p.Article

Four human breast cancer cell lines with biallelic inactivating α-catenin gene mutationsHOLLESTELLE, Antoinette; ELSTRODT, Fons; TIMMERMANS, Mieke et al.Breast cancer research and treatment. 2010, Vol 122, Num 1, pp 125-133, issn 0167-6806, 9 p.Article

Copy Number Alterations that Predict Metastatic Capability of Human Breast CancerYI ZHANG; MARTENS, John W. M; YU, Jack X et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 9, pp 3795-3801, issn 0008-5472, 7 p.Article

BRCA1 Mutation and Young Age Predict Fast Breast Cancer Growth in the Dutch, United Kingdom, and Canadian Magnetic Resonance Imaging Screening TrialsTILANUS-LINTHORST, Madeleine M. A; OBDEIJN, Inge-Marie; GILBERT, Fiona J et al.Clinical cancer research. 2007, Vol 13, Num 24, pp 7357-7362, issn 1078-0432, 6 p.Article

Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancerKRIEGE, Mieke; BREKELMANS, Cecile T. M; TILANUS-LINTHORST, Madeleine M. A et al.Breast cancer research and treatment. 2006, Vol 100, Num 1, pp 109-119, issn 0167-6806, 11 p.Article

How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer : a retrospective studySIEUWERTS, Anieta M; MEIJER-VAN GELDER, Marion E; TIMMERMANS, Mieke et al.Clinical cancer research. 2005, Vol 11, Num 20, pp 7311-7321, issn 1078-0432, 11 p.Article

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predispositionKRIEGE, Mieke; BREKELMANS, Cecile T. M; MULLER, Sara H et al.The New England journal of medicine. 2004, Vol 351, Num 5, pp 427-437, issn 0028-4793, 11 p.Article

Tumor tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancerSCHROHL, Anne-Sofie; HOLTEN-ANDERSEN, Mads N; PETERS, Harry A et al.Clinical cancer research. 2004, Vol 10, Num 7, pp 2289-2298, issn 1078-0432, 10 p.Article

RNA Expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: Correlation with chemotherapeutic responseBURGER, Herman; FOEKENS, John A; LOOK, Maxime P et al.Clinical cancer research. 2003, Vol 9, Num 2, pp 827-836, issn 1078-0432, 10 p.Article

The prognostic value of polymorphonuclear leukocyte elastase in patients with primary breast cancerFOEKENS, John A; RIES, Christian; LOOK, Maxime P et al.Cancer research (Baltimore). 2003, Vol 63, Num 2, pp 337-341, issn 0008-5472, 5 p.Article

Mutant E-cadherin breast cancer cells do not display constitutive Wnt signalingDE WETERING, Marc Van; BARKER, Nick; HARKES, I. Clara et al.Cancer research (Baltimore). 2001, Vol 61, Num 1, pp 278-284, issn 0008-5472Article

Clinical relevance of biologic factors in male breast cancerMEIJER-VAN GELDER, Marion E; LOOK, Maxime P; BOLT-DE VRIES, Joan et al.Breast cancer research and treatment. 2001, Vol 68, Num 3, pp 249-260, issn 0167-6806Article

Differences in Natural History between Breast Cancers in BRCA1 and BRCA2 Mutation Carriers and Effects of MRI Screening-MRISC, MARIBS, and Canadian Studies CombinedHEIJNSDIJK, Eveline A. M; WARNER, Ellen; WARREN, Ruth M. L et al.Cancer epidemiology, biomarkers & prevention. 2012, Vol 21, Num 9, pp 1458-1468, issn 1055-9965, 11 p.Article

Association of rare MSH6 variants with familial breast cancerWASIELEWSKI, Marijke; RIAZ, Muhammad; SCHUTTE, Mieke et al.Breast cancer research and treatment. 2010, Vol 123, Num 2, pp 315-320, issn 0167-6806, 6 p.Article

CHEK2 1100deIC and male breast cancer in the NetherlandsWASIELEWSKI, Marijke; DEN BAKKER, Michael A; VAN DEN OUWELAND, Ans et al.Breast cancer research and treatment. 2009, Vol 116, Num 2, pp 397-400, issn 0167-6806, 4 p.Article

DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patientsNIMMRICH, Inko; SIEUWERTS, Anieta M; MAGDOLEN, Viktor et al.Breast cancer research and treatment. 2008, Vol 111, Num 3, pp 429-437, issn 0167-6806, 9 p.Article

Association of an Extracellular Matrix Gene Cluster with Breast Cancer Prognosis and EndocrineTherapy ResponseHELLEMAN, Jozien; JANSEN, Maurice P. H. M; BERNS, Els M. J. J et al.Clinical cancer research (Print). 2008, Vol 14, Num 17, pp 5555-5564, issn 1078-0432, 10 p.Article

Roles of Radiotherapy and Chemotherapy in the Development of Contralateral Breast CancerHOONING, Maartje J; ALEMAN, Berthe M. P; HAUPTMANN, Michael et al.Journal of clinical oncology. 2008, Vol 26, Num 34, pp 5561-5568, issn 0732-183X, 8 p.Article